New York, California OK rate increases for pet insurance provider Trupanion, and investors cheer
Shares of Trupanion Inc. (TRUP) jumped after hours on Thursday after the pet-insurance provider announced that California and New York approved double-digit rate increases, saying that the hikes were "necessary in today's rising cost of veterinary care environment." California approved a rate increase of more than 12%, while New York approved a requested 18% rate increase, the company said. Margi Tooth, Trupanion's president, said the company believed "the rising cost of veterinary care will only increase the need for Trupanion in the months and years ahead." Executives said its full-year forecast, issued on May 4, hadn't included the approvals from the two states. And they said they were still hoping to deliver positive free cash flow in the fourth quarter, helped by spending cuts and rising vet-care costs. Tooth said the rate approvals were "a net positive to our balance sheet." Shares rose 16.4% after hours.
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-22-23 1645ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom